Component
Glucagon
Pancreatic peptide hormone.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
Where it participates (unsigned role)
HCl infusion causing acute mineral acidemia raised plasma potassium in the conscious-dog experiment.
Experimental context and source evidence
- endpoint
- HCl infusion causing acute mineral acidemia raised plasma potassium in the conscious-dog experiment.
- experimental-exposure
- Experimental acute mineral acidemia with hyperkalemia; not potassium deficiency or excessive potassium intake.
- experimental_model
- Twelve conscious dogs with portal/hepatic/systemic sampling; beta-hydroxybutyric acid 7 mEq/kg or HCl 3 mEq/kg infused over 30 minutes; additional anesthetized and obstructed-urinary-tract studies.
- limitations
- Acute HCl infusion, not every acidosis; portal glucagon rose and direct H/K exchange was not isolated.
- nutrient_topic
- Potassium research collection; topical membership is not evidence of a direct dietary effect. · Potassium
- organism
- Canis lupus familiaris
- plain_language
- Acid type affected the potassium response; a rise in blood potassium did not imply excess potassium intake.
- primary_references
- [adrogue-1985-acid-infusion] Role of the endocrine pancreas in the kalemic response to acute metabolic acidosis in conscious dogs (1985). https://www.jci.org/articles/view/111775 DOI: 10.1172/JCI111775
- tissue_or_cell_type
- systemic and splanchnic circulation
Potassium: cross-nutrient mechanisms and deficiency (2026-09-17) · lines 1151–1162
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Twelve conscious dogs with portal/hepatic/systemic sampling; beta-hydroxybutyric acid 7 mEq/kg or HCl 3 mEq/kg infused over 30 minutes; additional anesthetized and obstructed-urinary-tract studies. · source_derived_draft · unverified_draft
### hcl-acidemia-raises-plasma-k HCl infusion causing acute mineral acidemia raised plasma potassium in the conscious-dog experiment. Condition category: normal nutrient_topic: Potassium research collection; topical membership is not evidence of a direct dietary effect. plain_language: Acid type affected the potassium response; a rise in blood potassium did not imply excess potassium intake. organism: Canis lupus familiaris tissue_or_cell_type: systemic and splanchnic circulation experimental_model: Twelve conscious dogs with portal/hepatic/systemic sampling; beta-hydroxybutyric acid 7 mEq/kg or HCl 3 mEq/kg infused over 30 minutes; additional anesthetized and obstructed-urinary-tract studies. limitations: Acute HCl infusion, not every acidosis; portal glucagon rose and direct H/K exchange was not isolated. experimental-exposure: Experimental acute mineral acidemia with hyperkalemia; not potassium deficiency or excessive potassium intake. endpoint: HCl infusion causing acute mineral acidemia raised plasma potassium in the conscious-dog experiment. [adrogue-1985-acid-infusion] Role of the endocrine pancreas in the kalemic response to acute metabolic acidosis in conscious dogs (1985). https://www.jci.org/articles/view/111775 DOI: 10.1172/JCI111775
Complete structured claim and evidenceSomatostatin suppressed splanchnic glucose output by 50–100% for five hours after a 60-hour fast; the overnight-fast reduction was transient.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Healthy humans; somatostatin, glucose infusion to maintain euglycemia, organ exchange measurements.
- limitations
- Insulin and glucagon were both suppressed. The experiment does not isolate glucagon alone.
- nutrient_topic
- Fasting physiological-state collection; human protocols, cellular deprivation and refeeding are distinguished. · Fasting / abstention from energy intake
- plain_language
- Hormonal control changed with the fasting state.
- primary_references
- Role of basal glucagon levels in the regulation of splanchnic glucose output and ketogenesis in insulin-deficient humans. · 1984 · https://pubmed.ncbi.nlm.nih.gov/6146427/ · DOI 10.1111/j.1475-097x.1984.tb00117.x
Fasting: fuel switching, nutrient sensing, ketone signaling, nutrient dependencies and refeeding (2026-09-18) · lines 96–102
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Healthy humans; somatostatin, glucose infusion to maintain euglycemia, organ exchange measurements. · source_derived_draft · unverified_draft
## fast-hormone-withdrawal Hormonal control changed with the fasting state. Somatostatin suppressed splanchnic glucose output by 50–100% for five hours after a 60-hour fast; the overnight-fast reduction was transient. Model: Healthy humans; somatostatin, glucose infusion to maintain euglycemia, organ exchange measurements. Limitations: Insulin and glucagon were both suppressed. The experiment does not isolate glucagon alone. Evidence access: Primary abstract Role of basal glucagon levels in the regulation of splanchnic glucose output and ketogenesis in insulin-deficient humans. · 1984 · https://pubmed.ncbi.nlm.nih.gov/6146427/ · DOI 10.1111/j.1475-097x.1984.tb00117.x
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.